Recruitment of a Project technical support-III at Dr. Reddy’s Institute of Life Sciences,
Hyderabad for the ICMR sponsored project “Prediction of Idiosyncratic Drug Induced
Liver Injury (iDILI): A comprehensive in silico, in vitro and in vivo based multi-tier
screening approach”
Brief description: : iDILI is the major cause of drug attrition during toxicity trials and even
withdrawal from postmarketing. Bile salt export pump (BSEP/ABCB11) inhibition is a major
contributor to iDILI. The present project aims to devise an ensemble-docking based screening
approach to rank the existing and approved drugs for possible iDILI effects which will be
further verified in appropriately developed cellular and in vivo zebrafish models.
This project
is a large-scale screening initiative of approved and existing drugs for possible iDILI effects
utilizing multi-disciplinary approaches.
Principal Investigator: Dr. Sandipan Chakraborty, Associate
Principal Research Scientist, Dr.
Reddy’s Institute of Life Sciences, Hyderabad
Co-Principal Investigators: Dr. Kishore Parsa, Principal Research Scientis and Dr. Kiranam
Sr. Principal Research Scientist, Dr. Reddy’s Institute of Life Sciences, Hyderabad
Fellowship Duration: Initial appointment for 1 year; extendable depending on satisfactory
yearly performance or the continuation of the project
Stipend and other allowances: Rs. 28000 + 27% HRA
Qualifications: Master’s Degree in Biological/Chemical/Physical/Agricultural Sciences.
Applicants with GATE/UGC-CSIR NET (JRF/LS) /DBT-JRF scores will be preferred.
Age Limit: 35 years. The upper age limit is relaxable up to 5 years for candidates belonging
to scheduled castes/Scheduled Tribes/OBC, physically handicapped and female applicants.
Application Procedure: Applicants are requested to e-mail their CV with a cover letter as a
SINGLE PDF to the PI at sandipanc@drils.org or sandipanchakraborty.13@gmail.com ASAP
as well as mark to hr@drils.org
Date and time of interview: Final date and time will be informed to shortlisted applicants only
via email
0 Comments